BRIACELL THERAP Gross Profit

Gross Profit of BCTX for past 10 years: annual, quarterly and twelve month trailing (TTM) including Gross Profit growth rates and interactive chart. Gross profit is a company's net sales revenue minus its cost of goods sold (or cost of revenue). In other words, it is the sales revenue a company retains after incurring the direct costs associated with producing the goods it sells, and the services it provides.


Highlights and Quick Summary

  • Gross Profit for the quarter ending October 31, 2022 was $-3.72 Thousand (a -1.51% decrease compared to previous quarter)
  • Year-over-year quarterly Gross Profit decreased by -3.83%
  • Annual Gross Profit for 2022 was $-15.2 Thousand (a -3.13% decrease from previous year)
  • Annual Gross Profit for 2021 was $-15.6 Thousand (a 12.11% increase from previous year)
  • Annual Gross Profit for 2020 was $-14 Thousand (a -2.24% decrease from previous year)
  • Twelve month Gross Profit ending October 31, 2022 was $-15.1 Thousand (a -0.65% decrease compared to previous quarter)
  • Twelve month trailing Gross Profit increased by 1.51% year-over-year
Trailing Gross Profit for the last four month:
31 Oct '22 30 Apr '22 31 Jan '22 31 Oct '21
$-15.1 Thousand $-15.2 Thousand $-15.1 Thousand $-14.9 Thousand
Visit stockrow.com/BCTX for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical Gross Profit of BRIACELL THERAP

Most recent Gross Profitof BCTX including historical data for past 10 years.

Interactive Chart of Gross Profit of BRIACELL THERAP

BRIACELL THERAP Gross Profit for the past 10 Years (both Annual and Quarterly)

(All values are in $ million)

Year Q1 Q2 Q3 Q4 Fiscal Year
2022 $-0.0 $-0.0 $-0.0 $-0.02
2021 $-0.0 $-0.0 $-0.0 $-0.02
2020 $-0.0 $-0.0 $-0.0 $-0.0 $-0.01
2019 $-0.01
2018 $-0.01
2017 $0.0
2016 $-0.0

Business Profile of BRIACELL THERAP

Sector: Healthcare
Industry: Biotechnology